Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

A novel angiotensin II binding site in murine tissues.

Herblin WF, Barbera F, Diamond S, Gibson RE, Timmermans P.

Life Sci. 1998;63(3):223-34.

PMID:
9698052
2.

Nonpeptide angiotensin II receptor antagonists: in vivo inhibition of [125I-Sar1,Ile8]angiotensin II binding by losartan, EXP597 and L-159,282 in rats.

Wong PC, Herblin WF, Barbera FA, Bernard R, Bozarth TA, Watson CA, Gibson RE.

Clin Exp Hypertens. 1996 Feb;18(2):189-200.

PMID:
8869000
3.

A rapid, high capacity assay for basic fibroblast growth factor binding.

Herblin WF, Barbera FA.

Life Sci. 1995 Mar 3;56(15):1257-64.

PMID:
8614243
4.

Basic fibroblast growth factor and receptor expression in human ovarian cancer.

Crickard K, Gross JL, Crickard U, Yoonessi M, Lele S, Herblin WF, Eidsvoog K.

Gynecol Oncol. 1994 Nov;55(2):277-84.

PMID:
7959296
5.

Identification and concerted function of two receptor binding surfaces on basic fibroblast growth factor required for mitogenesis.

Springer BA, Pantoliano MW, Barbera FA, Gunyuzlu PL, Thompson LD, Herblin WF, Rosenfeld SA, Book GW.

J Biol Chem. 1994 Oct 28;269(43):26879-84.

6.

Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator.

Takano S, Gately S, Neville ME, Herblin WF, Gross JL, Engelhard H, Perricone M, Eidsvoog K, Brem S.

Cancer Res. 1994 May 15;54(10):2654-60.

7.

Inhibition of angiogenesis as a strategy for tumor growth control.

Herblin WF, Gross JL.

Mol Chem Neuropathol. 1994 Feb-Apr;21(2-3):329-36. Review.

PMID:
7522007
8.

New perspectives in angiotensin system control.

Timmermans PB, Wong PC, Chiu AT, Herblin WF, Smith RD.

J Hum Hypertens. 1993 Aug;7 Suppl 2:S19-31. Review.

PMID:
8230085
9.

Angiotensin II receptors and angiotensin II receptor antagonists.

Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD.

Pharmacol Rev. 1993 Jun;45(2):205-51. Review. No abstract available.

PMID:
8372104
10.

Effects of modulation of basic fibroblast growth factor on tumor growth in vivo.

Gross JL, Herblin WF, Dusak BA, Czerniak P, Diamond MD, Sun T, Eidsvoog K, Dexter DL, Yayon A.

J Natl Cancer Inst. 1993 Jan 20;85(2):121-31.

PMID:
8418301
11.

Angiotensin II receptors in rabbit vascular grafts.

Hausner EA, Turner MJ, Trzaskos JM, Herblin WF.

Biochem Biophys Res Commun. 1993 Jan 15;190(1):27-32.

PMID:
8422252
12.

Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors.

Brem S, Tsanaclis AM, Gately S, Gross JL, Herblin WF.

Cancer. 1992 Dec 1;70(11):2673-80.

PMID:
1423198
13.

Angiotensin II receptors and functional correlates.

Timmermans PB, Benfield P, Chiu AT, Herblin WF, Wong PC, Smith RD.

Am J Hypertens. 1992 Dec;5(12 Pt 2):221S-235S. Review.

PMID:
1290617
14.

Angiotensin II receptor antagonists and receptor subtypes.

Wong PC, Chiu AT, Duncia JV, Herblin WF, Smith RD, Timmermans PB.

Trends Endocrinol Metab. 1992 Aug;3(6):211-7.

PMID:
18407102
15.

Angiotensin II receptor subtypes.

Timmermans PB, Chiu AT, Herblin WF, Wong PC, Smith RD.

Am J Hypertens. 1992 Jun;5(6 Pt 1):406-10. Review.

PMID:
1524767
16.

Pharmacology of nonpeptide angiotensin II receptor antagonists.

Smith RD, Chiu AT, Wong PC, Herblin WF, Timmermans PB.

Annu Rev Pharmacol Toxicol. 1992;32:135-65. Review. No abstract available.

PMID:
1605566
17.

Multiple angiotensin receptors: selective ligands and functional correlates.

Timmermans PB, Chiu AT, Herblin WF, Smith RD, Wong PC.

Jpn J Pharmacol. 1992;58 Suppl 2:135P-141P. Review. No abstract available.

18.

Binding sites for basic fibroblast growth factor on solid tumors are associated with the vasculature.

Herblin WF, Gross JL.

EXS. 1992;61:214-8. No abstract available.

PMID:
1377532
19.

Tumor growth regulation by modulation of basic fibroblast growth factor.

Gross JL, Herblin WF, Eidsvoog K, Horlick R, Brem SS.

EXS. 1992;61:421-7. No abstract available.

PMID:
1319779
20.

Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.

Wong PC, Hart SD, Chiu AT, Herblin WF, Carini DJ, Smith RD, Wexler RR, Timmermans PB.

J Pharmacol Exp Ther. 1991 Nov;259(2):861-70.

PMID:
1941632
21.

Localization of angiotensin II receptor subtypes in the rabbit adrenal and kidney.

Herblin WF, Diamond SM, Timmermans PB.

Peptides. 1991 May-Jun;12(3):581-4.

PMID:
1923936
22.

Further studies on the selectivity of DuP 753, a nonpeptide angiotensin II receptor antagonist.

Wong PC, Tam SW, Herblin WF, Timmermans PB.

Eur J Pharmacol. 1991 Apr 17;196(2):201-3. No abstract available.

PMID:
1651874
23.

Angiotensin II receptor heterogeneity.

Herblin WF, Chiu AT, McCall DE, Ardecky RJ, Carini DJ, Duncia JV, Pease LJ, Wong PC, Wexler RR, Johnson AL, et al.

Am J Hypertens. 1991 Apr;4(4 Pt 2):299S-302S.

PMID:
1854455
24.
25.

An automated filtration assay for protein kinase C ligands.

Gross JL, Enders-Stephens L, Herblin WF.

Anal Biochem. 1991 Feb 15;193(1):149-54.

PMID:
2042740
26.

Nonpeptide angiotensin II receptor antagonists.

Timmermans PB, Wong PC, Chiu AT, Herblin WF.

Trends Pharmacol Sci. 1991 Feb;12(2):55-62. Review.

PMID:
2024289
27.

The biodistribution of 111In-anti-bFGF in a variety of tumors. Correlation with cell-binding assays.

Knox SJ, Brown JM, McGann J, Sutherland W, Goris ML, Herblin WF, Gross JL.

Ann N Y Acad Sci. 1991;638:497-502. No abstract available.

PMID:
1785829
28.

Basic fibroblast growth factor: a potential autocrine regulator of human glioma cell growth.

Gross JL, Morrison RS, Eidsvoog K, Herblin WF, Kornblith PL, Dexter DL.

J Neurosci Res. 1990 Dec;27(4):689-96.

PMID:
1964181
29.

Evidence for the presence of angiotensin II-type 1 receptors in brain.

Wamsley JK, Herblin WF, Alburges ME, Hunt M.

Brain Res Bull. 1990 Sep;25(3):397-400.

PMID:
2292036
30.

Characterization of specific [3H]dimethylstaurosporine binding to protein kinase C.

Gross JL, Herblin WF, Do UH, Pounds JS, Buenaga LJ, Stephens LE.

Biochem Pharmacol. 1990 Jul 15;40(2):343-50.

PMID:
2375770
31.

Basic fibroblast growth factor-like activity and receptors are expressed in a human glioma cell line.

Morrison RS, Gross JL, Herblin WF, Reilly TM, LaSala PA, Alterman RL, Moskal JR, Kornblith PL, Dexter DL.

Cancer Res. 1990 Apr 15;50(8):2524-9. Erratum in: Cancer Res 1990 Aug 1;50(15):4825.

32.

Identification of angiotensin II receptor subtypes.

Chiu AT, Herblin WF, McCall DE, Ardecky RJ, Carini DJ, Duncia JV, Pease LJ, Wong PC, Wexler RR, Johnson AL, et al.

Biochem Biophys Res Commun. 1989 Nov 30;165(1):196-203.

PMID:
2590220
33.

Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivo.

Reilly TM, Taylor DS, Herblin WF, Thoolen MJ, Chiu AT, Watson DW, Timmermans PB.

Biochem Biophys Res Commun. 1989 Oct 31;164(2):736-43.

PMID:
2479375
34.

Discrimination of angiotensin II receptor subtypes by dithiothreitol.

Chiu AT, McCall DE, Nguyen TT, Carini DJ, Duncia JV, Herblin WF, Uyeda RT, Wong PC, Wexler RR, Johnson AL, et al.

Eur J Pharmacol. 1989 Oct 24;170(1-2):117-8. No abstract available.

PMID:
2612561
35.

Photoinactivation of the mu opioid receptor using a novel synthetic morphiceptin analog.

Herblin WF, Kauer JC, Tam SW.

Eur J Pharmacol. 1987 Jul 23;139(3):273-9.

PMID:
2822433
37.
38.

The selective inhibition of dopamine uptake by a tricyclic imine.

Herblin WF.

Neurochem Res. 1977 Feb;2(1):111-6. doi: 10.1007/BF00966025.

PMID:
24271853
39.

A simple colorimetric assay for catechol-O-methyl transferase.

Herblin WF.

Anal Biochem. 1973 Jan;51(1):19-22. No abstract available.

PMID:
4688015
40.

Amantadine and catecholamine uptake.

Herblin WF.

Biochem Pharmacol. 1972 Jul 15;21(14):1993-5. No abstract available.

PMID:
4649347
41.

Interaction of norepinephrine with subcellular fractions of rat brain. I. Characteristics of norepinephrine uptake.

Herblin WF, O'Brien RD.

Brain Res. 1968 May;8(2):298-309. No abstract available.

PMID:
5652722
42.

Transfer of conditioned responses from trained rats to untrained rats by means of a brain extract.

Rosenblatt F, Farrow JT, Herblin WF.

Nature. 1966 Jan 1;209(5018):46-8. No abstract available.

PMID:
5925330
43.

THE BINDING OF HEAVY METAL IONS BY PAPAIN.

HERBLIN WF, RITT PE.

Biochim Biophys Acta. 1964 Jun 1;85:489-90. No abstract available.

PMID:
14194864

Supplemental Content

Loading ...
Support Center